# EDGAR Filing Document

**Accession Number:** 0001421744
**File Stem:** 0001104659-25-068150
**Filing Date:** 2025-7
**Character Count:** 2152
**Document Hash:** d7e2bf9c9f99230c29e050a5422be74e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-068150.hdr.sgml**: 20250716

**ACCESSION NUMBER**: 0001104659-25-068150

**CONFORMED SUBMISSION TYPE**: 253G2

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250716

**DATE AS OF CHANGE**: 20250715

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cytonics Corp
- **CENTRAL INDEX KEY:** 0001421744
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 208883869
- **STATE OF INCORPORATION:** FL

**FILING VALUES:**
- **FORM TYPE:** 253G2
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 024-12533
- **FILM NUMBER:** 251125805

**BUSINESS ADDRESS:**
- **STREET 1:** 658 W INDIANTOWN RD
- **STREET 2:** SUITE 214
- **CITY:** JUPITER
- **STATE:** FL
- **ZIP:** 33458-7535
- **BUSINESS PHONE:** (561) 575-4451

**MAIL ADDRESS:**
- **STREET 1:** 658 W. INDIANTOWN ROAD
- **STREET 2:** SUITE 214
- **CITY:** JUPTER
- **STATE:** FL
- **ZIP:** 33458

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CYTONICS CORP
- **DATE OF NAME CHANGE:** 20071219

**Filed pursuant to Rule 253(g)(2)<br> File No. 024-12533**

**SUPPLEMENT DATED JULY 15, 2025**

**TO OFFERING CIRCULAR DATED MARCH 17, 2025**

**Cytonics Corporation**

![](tm2521025d1_253g2img01.jpg)

**658 West Indiantown Road, Suite 214, Jupiter, FL 33458**

**(443) 827-8135**

**www.cytonics.com**

The purpose of this supplement is to:

&nbsp;&nbsp;&nbsp;&nbsp;· Announce and update to the closing of the Cytonics Corporation (the "Company" or "Cytonocs") Regulation A offering.

*<u>Closing of Regulation A Offering</u>*

The Company intends to terminate the offering for its Common Stock described in the Offering Circular. No further subscriptions will be accepted for the current offering after August 27, 2025 (the "Termination Date"). Subscriptions in the offering will be accepted up to that date and processed as promptly as possible. None of the terms of the offering have been changed. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.